209 related articles for article (PubMed ID: 33789744)
1. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.
Wang J; Hu HJ; Liu ZK; Liu JJ; Wang SS; Cheng Q; Chen HZ; Song M
Transl Neurodegener; 2021 Mar; 10(1):12. PubMed ID: 33789744
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.
Zhang Z; Obianyo O; Dall E; Du Y; Fu H; Liu X; Kang SS; Song M; Yu SP; Cabrele C; Schubert M; Li X; Wang JZ; Brandstetter H; Ye K
Nat Commun; 2017 Mar; 8():14740. PubMed ID: 28345579
[TBL] [Abstract][Full Text] [Related]
3. Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer's disease.
Wang SS; Liu ZK; Liu JJ; Cheng Q; Wang YX; Liu Y; Ni WW; Chen HZ; Song M
J Nanobiotechnology; 2021 Aug; 19(1):249. PubMed ID: 34412639
[TBL] [Abstract][Full Text] [Related]
4. The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer's Disease.
Song M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142134
[TBL] [Abstract][Full Text] [Related]
5. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease.
Liao J; Chen C; Ahn EH; Liu X; Li H; Edgington-Mitchell LE; Lu Z; Ming S; Ye K
Neuropharmacology; 2021 Oct; 197():108737. PubMed ID: 34343610
[TBL] [Abstract][Full Text] [Related]
6. Delta-secretase triggers Alzheimer's disease pathologies in wild-type hAPP/hMAPT double transgenic mice.
Wu Z; Liu X; Cheng L; Ye K
Cell Death Dis; 2020 Dec; 11(12):1058. PubMed ID: 33311478
[TBL] [Abstract][Full Text] [Related]
7. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.
Zhang Z; Song M; Liu X; Su Kang S; Duong DM; Seyfried NT; Cao X; Cheng L; Sun YE; Ping Yu S; Jia J; Levey AI; Ye K
Nat Commun; 2015 Nov; 6():8762. PubMed ID: 26549211
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer's Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells.
Cheng Q; Ma X; Liu J; Feng X; Liu Y; Wang Y; Ni W; Song M
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175445
[TBL] [Abstract][Full Text] [Related]
9. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
10. Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer's disease.
Xia Y; Wang ZH; Zhang Z; Liu X; Yu SP; Wang JZ; Wang XC; Ye K
Prog Neurobiol; 2021 Sep; 204():102113. PubMed ID: 34166772
[TBL] [Abstract][Full Text] [Related]
11. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
12. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
[TBL] [Abstract][Full Text] [Related]
13. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
14. δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities.
Zhang Z; Tian Y; Ye K
Transl Neurodegener; 2020; 9():1. PubMed ID: 31911834
[TBL] [Abstract][Full Text] [Related]
15. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
[TBL] [Abstract][Full Text] [Related]
16. Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.
Chen C; Zhou Y; Wang H; Alam A; Kang SS; Ahn EH; Liu X; Jia J; Ye K
EMBO J; 2021 Sep; 40(17):e106320. PubMed ID: 34260075
[TBL] [Abstract][Full Text] [Related]
17. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
Hook G; Hook V; Kindy M
J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
19. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease.
Wang ZH; Gong K; Liu X; Zhang Z; Sun X; Wei ZZ; Yu SP; Manfredsson FP; Sandoval IM; Johnson PF; Jia J; Wang JZ; Ye K
Nat Commun; 2018 May; 9(1):1784. PubMed ID: 29725016
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice.
Qian Z; Li B; Meng X; Liao J; Wang G; Li Y; Luo Q; Ye K
Neuropsychopharmacology; 2024 Feb; 49(3):620-630. PubMed ID: 38030711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
